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A new scintigraphic method in cases of persistence or recurrence of
secondary or tertiary hyperparathyroidism. C. Billotey, E. Sarfati, J.D.
Rain, and Y Najean, Services de mCdecine nucléaire et de chirurgie generate,
HOpital Saint-Louis, Paris, France. The aim of the study was to evaluate the
interest of a new monoisotopic parathyroid scintigraphic method using
MIBI-Tc99m, factor analysis of dynamic structures (FADS) and single
photon emission computed tomography (SPECT) in cases of persistence
or recurrence of secondary or tertiary hyperparathyroidism. A total of 20
patients suffering from chronic renal failure and obvious and severe
biological hyperparathyroidism (HPT) were studied: 17 patients were
permanently dialyzed; 3 had a kidney transplantation and suffered from
recurrent and autonomous hyperparathyroidisni (tertiary HPT); 6 patients
had a multinodular thyroid goiter. All the patients underwent surgery I
day to 6 months after scintigraphy. During surgery, 15 abnormal glands
were found in the neck in 13 patients, 5 in the anterior mediastinum in 4
patients; 2 patients had hyperplasia of a forearm parathyroid graft. In one
patient, no abnormal gland was found. One patient was cured only after
two successful surgeries. Despite removing one cervical gland, 2 patients
still suffered from HPT (whereas scintigraphy also showed mediastinal
uptake). A dynamic acquisition of 25 to 30 One-minute images was started
at the time of intravenous bolus injection of 15 to 20 mCi of MIBI-Tc99m
with a pinhole collimator centered on the thyroid area. FADS applied on
this initial acquisition allows a display of the uptake of the enlarged
parathyroid glands in the thyroid uptake area. Lateral planar views of the
neck (600 kps) were acquired on a 128 x 128 matrix with a parallel hole
collimator. Then a tomographic acquisition (SPECT) on the neck and
thorax was performed (360° 64 steps - 64 >< 64 matrix).
Unit, CHU Nerd, Amiens, France. To assess the sensitivity (Sc) and
specificity (Sp) of indirect radionuclide cystography (TRC), we compared
it with micturating cystourethrography (MCUG) to detect vesico-ureteric
reflux (VUR). Thirty-four children (age <2 years, 9; >2 years, 25; mean
age 4, range 2 to 13), underwent IRC and MCUG within 3 months because
of severe urinary tract infection. Children with obstructive uropathy and
neurological bladder were excluded, as were children in whom we could
not obtain micturition during examination (N = 8). IRC consisted of iv.
administration of °9technetium mercaptoacetyltriglycine (MAG 3) (6
mCurie/1.73 m2). During micturation a sequence of 30 pictures per mm
were taken and analyzed by computer (Sopha Mediea). VUR was
diagnosed when both the scan and the time-activity curves over the kidney
and ureter showed a simultaneous increase in activity. MCUG was
performed, after catheterization of the bladder in girls and a suprapubic
puncture in boys. Three fillings were performed in each test.
Total study
population
VUR grade 1I
age <2 <2 years,
n renal units: 68 years, n: 18 n: 37
MCUG MCUG MCUG
+ -. + +
IRC + 13 1 7 1 6 0
— 22 32 6 4 11 20
Se 0.37 Sp 0.96 Se 0.54 Sp 0.8 Se 0.35 Spl.0
Gland number found
Scintigraphic Patient By By
results number scintigraphie surgery Course of PTH
False negative 0
16 cure: 15 pts
2 persistence: 2 pts
3 cure: I pt
I cure: I pt
0 unchanged: I pt
In conclusion, this new seintigraphie method seems to he very sensitive
(78%; 18 of 23) to detect hyperplastie glands in eases of persistent or
recurrent secondary or tertiary hyperparathyroidism, even in ease of
mediastinal glands or associated thyroid abnormalities. Combining scm-
tigraphy and ultrasonography results allows to detect 83% (19/23) of the
abnormal glands.
MAG 3 indirect radionuclide cystography for the detection of vesico-
ureteric reflux: What are the indications considering the moderate
sensitivity and the high specificity of the method. B. Boudailliez, J. Al
Hosri, I P. Canarelli, J.P. Neveu, Y Ricard, avid J. Fonroget, Paediatric
Department, Nephrolo,ry Unit, Nuclear Medicine Department, and Surgery
Our results showed a moderate Se and a high Sp of IRC to detect VUR
independant of age. In the literature on the use of IRC using DTPA as the
tracer, we found a great disparity in Se (from 0.41 to 0.74) and in Sp (froni
0.44 to 0.9). Because 99TcMAG 3 has a better extraction rate, it might
provide a higher Sp in IRC compared to DTPA. It appears that IRC and
MCUG, which are regarded as the gold standard to detect VUR, do not
recognize the same pathophysiological events, and an artificial bladder
filling may provoke VUR. On the contrary, MCUG might miss VUR, as
proven by subsequent positive investigations. Although IRC has many
potential advantages (lower radiation dose, no bladder catheterization),
the moderate Se reveals that TRC is not an ideal method to detect and
follow up on patients with VUR.
Benefits of measuring metformine in lactic acidosis being treated by
hemodialysis. E. ardineau, C. Maurouard, G. Houlbert, C. Bernadat, M.P,
Du Rose!, N. Frenkie4 Service de Nephrologie, Service vie Biochimie, Service
de Médecine 1, Centre Ho3pilulier d'Alencon, France. Lactic aeidosis caused
by an overdose of biguanide in diabetic patients can be successfully treated
by bicarbonate hemodialysis. However, the existence of a deep compart..
ment, a source of release of metforminc (MET) in the circulatory flow,
emphasizes the benefits of measuring MET in erythrocytes (ERY) and in
plasma (PL) by certain authors, to guide them in determining the duration
of dialysis treatment (DT). The turnaround time for these assays remain
a source of difficulties. We report here a personal observation which allows
us to identi' two distinctive purposes in the care of these patients: (1)
treatment of toxication with the notion of correlation between plasmatic
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creatinine and ERY MET; (2) treatment of lactic acidosis with the notion
of correlation between pH and PL MET. Mrs. V., 64 years old, plethoric
diabetic, treated with 2650 mg of MET per day, with an estimated
creatininc clearance of 80 mi/mn, is hospitalized following hypovolemia
caused by a rotavirus diarrhea, associated with furosemide treatment 60
mg per day and perindopril 2 mg per day. The creatinine level is 990
i.rmol/l, pH at 6.87, blood lactates at 1460 mg/I. A diagnosis of acute renal
failure output accompanied by lactic acidosis due to MET overdose was
made. The patient is hemodialyzed (using a generator MONITRAL S,
sodium bicarbonate capillary: CA 130). The first session lasted for 15
hours which permitted the pH to return to 7.32 and the lactate level to 897
mg/liter without affecting consciousness or hemodynamic constants. Four
hemodialysis sessions were necessary before self-sufficient renal function
was obtained. The evolution of pH and MET are shown on the following
graph. The MET assay was done by liquid chromatography. Normal levels
are: ERY MET < 1.65 mg/liter, PL MET < 1.34 mg/liter.
This graph shows that despite the first prolonged dialysis session there was
no purification of ERY MET, but even an increase in levels (the transfer
between the two compartments, blood and tissues, being very slow). The
clinical recovery of the acidotic patient was obtained because of the
purification of PL MET. ERY MET clearance occurs progressively,
without it being possible to affirm the beneficial role of dialysis sessions.
Pauci-immune crescentic glomerulonephritis and Sweet's syndrome. G.
Cardon, F. Bourdon, B. Catteau, C. Noel, M. Dracon, H. Bergoend, M.
Lecomle, G. Lelièvre, Service de NephrologieA, DermatologieA etAnatomo-
pathologie, CHR U de Lille, France. An acute febrile neutrophilic derma-
tosis associated with a pauci-immune crescentic glomerulonephritis was
observed in a 57-year-old female patient who presented a history of
obesity with carbohydrate intolerance and a heterogenous multi-nodular
goiter. Eight months before being hospitalized in the nephrology unit, this
patient presented a typical Sweet's syndrome: fever, malaise, a painful
erythemato-papulo rash, an inflammatory syndrome and neutrophiha. The
diagnosis was confirmed by skin biopsy; no associated neoplasia was found
(an association found in 20% of patients). With corticotherapy (pred-
nisolone 50 mg/day) a remission of the clinical symptomatology was
obtained. Five months later this same patient developed acute renal
failure with toxidcrmia after having taken Amoxicilline and Dielofenac
(creatinine at 3.7 dg/liter, moderate proteinuria and microscopic hematu-
na), which subsided completely after stopping these medications. Three
months later, fever, malaise, renal failure (creatinine at 30 dg/liter,
proteinuria at 3 glday and microscopic hematuria) and an inflammatory
syndrome led to hospitalization. Renal biopsy demonstrated crescentic
glnmerulonephritis (epithelial crescents in 7 of the 13 glomcruli) without
immune deposition on immunoiluoreseenee, Immunological study showed
the presence of eANCA (1/80) without other abnormalities. Methylpred-
nisolone by holus injection, continued orally, normalized renal function,
which remained normal during the 5-year follow-up period. The signifi-
cance of cANCA in the follow-up, and even possibly in the pathogenicity
of this dermatosis, remains uncertain. Here, the cANCA levels fluctuated
greatly (1/40 to 1/320) and appeared to have no relationship with the
cutaneous or renal manifestations. The pathophysiology of this dermatosis
is not yet well understood; there appears, however, to be a specific
neutrophilic activation. Organs such as the lungs and liver are occasionally
affected. The renal aspect produces proteinuria and/or hematuria, hut
rarely acute failure. This appears to he the first description of pauci-
immune crescentic glomerulonephritis associated with Sweet's syndrome.
Quality control of hemodialysis by the conductimetric method. B.
Coevoet, L. Aazih, T Petitclerc, B. Chlih, J. Brasseur, Service Néphrologie,
C.H. Saint-Quentin, B.? 608, F. 02100, C.H. U. La Pitié Salpétrière, Parts,
France. Even with good compliance of the patient to the dialysis prescrip-
tion, the efficacy of dialysis depuration can be deteriorated by several
factors: vascular access recirculation (RC), anticoagulation procedure
(ACP), switch of dialysate connectors (SWC), and a decrease of actual
blood flow rate. We present results on the influence of these factors on the
efficacy of depuration that can be monitored by a real time estimation of
effective urea clearance. Previous works showed that the effective urea
clearance (clearance corrected according to the effect of recirculation) can
he derived from conductivity measures at the dialysate inlet and outlet for
two conductivity values at the inlet. An original module (DIASCAN,
1-lospal R & D mt., France) implements this method to obtain in real time,
automatically, the ionic dialysance (D) every 20 or 30 minutes during the
dialysis session. The effect of the increase of the blood flow rate (300, 350
and 400 mI/mm) was tested in three patients during 33 dialysis sessions.
We evidenced a significant increase of D (from 169 to 187 mI/mm, P <
0.05) between 300 and 350 mI/mm, and a stability of D (187 to 180 mI/mm)
between 350 and 400 mI/mm. The effect of RC was tested on a patient with
two remote vascular accesses (jugular catheter and AV fistula) at several
recirculation rates R (%) created by an additional pump. The ratio
(DO-D)/DO, (DO: dialysanee without recirculation) was 8%, 16% and
24% for recirculation rates, respectively at 10%, 20% and 30%. There was
a fine correlation (r = 93) between D and the value predicted by the
formula proposed by Gotch using DO and R %. During 49 sessions with
heparin in the priming fluid, D was significantly higher than in 51 sessions
in the same conditions but without hepanin in the priming fluid (195 17
mI/mm vs. 170 8 mI/mm, P < 0.05). The switch of the dialysate
connectors decreased significantly the dialysance (178 19 mI/mm vs.
145 14 mI/mm, N = 21, P < 0.05) with a fine correlation with the
decrease predicted by the theonical formula using dialyzer KOA. The use
of a smaller fistula needle (17 g instead of 15 g) resulted in a decrease of
D by 10% for blood flow rate of 300 mI/mm (N = 9) and 350 mI/mm (N =
9). This is explained by a reduction of the actual blood flow rate as
confirmed by the bubble method. The described method permits a
continuous quality control of depuration, which then can be integrated
into a quality assurance process of the dialysis dose with further adapta-
tion of the parameters (dialysis time, blood flow rate) acting on it.
Comparison of plasma PCR, PP 65 antigenemia (AG) and viremia for
detection of human cytomegalovirus (HCMV) infection in renal trans-
plant recipients. P. Eckart, M. Campet, J. Brouard, F. Freymuth, C. Legoff
J.P. Ryckelynck, B. Hurault de Ligny, CHRU Clémenceau, Caen, France. We
prospectively compared the detection of HCMV DNA in plasma by PCR
(amplification of the 1E1 gene, detection by hybridization with a single
stranded DNA probe), pp 65 granulocytic antigenemia (AG) and viremia
(in cell culture fibroblast inoculated) in renal transplant recipients in order
to predict symptomatic HCMV infection. Blood samples were obtained
from 23 patients at weekly intervals for at least 6 months following
transplantation. Donor (D)/recipient (R) HCMV status were 5 D+/R—, 6
D—/R+, 5D+/R+, and 7 D—/R—. Symptomatic visceral HCMV infection
occurred in 4 of 5 D /R— patients.
Table 1. Sensitivity and negative predictive value for detection of
HCMV infection
Sensitivity 92.8% 85.7% 78.6%
Negative predictive values 87.5% 77.7% 70%
PCR AG Viremia
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Table 2. Longitudinal analysis of the 1st day (d) of ACMV detection
and the 1st d of HCMV negativation among symptomatic (S) VS
asymptomatie (AS) patients
P Mean(d) P
1st d detection S
AS
39 96
37 18.4
0.44 35 6.4
29 7.1
0.15
2st d negativation 5
AS
106 17.4
74.7 29.2
0.06 144.5 24.8
79.5 23.5
0.01
Viremia
mean (d) P
1st d detection 5
AS
41.3 10
31.5 11.1
0.21
1st d negativation S
AS
100.3 14.1
72.6 22.6
0.06
AG duration Higher level AG
——
mean (d) P mean (d) P
0.01 0,04
HCMV was never detected in 9 AS patients (1 D+/R—, I D—/D+, 7
D—/R—). Viremia appears to be the least sensitive. HCMV disease was
observed in a viremia negative patient. For AG: 1st d negativation is later,
duration is longer and the level is higher in HCMV patients. The plasma
PCR assay appeared to have the highest sensitivity and negative predictive
value for HCMV detection. High level AG was found to be correlated to
symptomatic visceral infection. A level of AG had to be determined to
predict a risk of HCMV disease.
Long-term impact of chronic HBV infection in kidney transplant
recipients. S. Fornairon, S. PoI, C. Legendre, F. Carnot, H. Kreis, Services de
Transplantation et d'Hépatologie, Hôpital Necker, Paris, France. The impact
of chronic HBV infection in kidney transplant recipients is still a matter of
debate. To clarify this issue and expand our experience, we retrospectively
studied 151 patients (35 females and 116 males, mean age 32 years) who
received 174 kidney grafts at our institution between January 1967 and
January 1994 and were chronic HBs Ag carriers. The mean follow-up was
120 months 83 (range 1 to 320 months). At least one liver biopsy was
performed in 131 patients, while 101 patients underwent at least two liver
biopsies. Markers of HBV infection, that is, serum HBV DNA and HBe
Ag, were present respectively in 75% and 54% of patients. The presence
of these markers was significantly associated with biopsy-proven cirrhosis
(P < 0.01). Spontaneous disappearance of HBe Ag was observed in only
30.6% of patients during the entire follow-up. Histological deterioration
was observed in 85.3% of the 101 patients with serial liver biopsy, after a
mean of 66 months. While 39% of these patients had a normal liver on the
first biopsy, only 6% had a normal liver on the last biopsy. Cirrhosis was
diagnosed in 28% of the 131 biopsied patients. Hepatocellular carcinoma
developed in 7 patients (4.6%), with an overall prevalence of 8.6% among
patients with cirrhosis, which is not significantly different from that
observed in the general population. At the end of follow-up, 69 (45.7%)
patients had a functional allograft, while 41(27.1%) patients had returned
to dialysis and 41(27.1%) had died. Death was related to liver disease in
15 cases (36%), to infection in 8 (20%) eases, to cancer (except for liver)
in 6 cases (15%) and to vascular disease in 8 cases (20%). Actuarial
patient survival of the 151 HB5-Ag+ recipients was not significantly
different from that of HBs-Ag—- recipients. In contrast, actuarial graft
survival was significantly better (P < 0.05) in HBs-Ag+ recipients
especially during the first five years post-transplantation. In summary,
renal transplantation modifies the natural history of HBV infection with
an increased frequency of viral replication episodes and a low rate of
spontaneous stop of viral replication. In contrast, HBV infection does not
clearly modify the course of renal transplantation. These encouraging
results may he extended to HCV infection.
Retrospective epidemiologic study of renal biopsies in Guadeloupe
(French Caribbean). J-M. Gabriel, F. Huncklet; Service de Nephrologie,
Pointe a Pitre, France. Four hundred and eighty-four renal biopsies (B)
were performed from 1974 to March 1994. Forty-seven B, without
adequate kidney tissue, were excluded from the study. Three hundred and
ninety-six patients underwent one B, 36 necessitated a second B, and five
persons had a third B. On average, 2 B were done each month with few
variations in time. The main age class was 15 to 34 years: 48% among
women versus 38% for men. The most common clinical symptoms at time
of B were: renal failure (50.3%), ncphrotic syndrome (47.8%), arterial
hypertension (46.3%), and hematuria (17.3%). In women the main
glomerulopathies were: nephrosis 19.3% (idiopathic nephrotic syndrome
with focal segmental sclerosis 12.1% or minimal change disease 7.2%),
lupus glomerulopathies 18.8%, nephroangioselerosis 8.7%, membranous
glomerulonephritis 8.6%, acute glomerulonephritis and IGA nephropathy
3.9%. Nephrosis (24.9%) was also the first histologic diagnosis (focal
segmental sclerosis 17.3%, minimal change disease 7.6%) encountered in
male biopsies, followed by membranous nephropathy 8.7%, acute glomer-
ulonephritis, HIV associated nephropathy and IGA nephropathy, 5.9%
each. Nephrosis and lupus glomerulopathy are more often diagnosed in
young women with nephrotic syndrome (with a mean age of 32.7 years for
patients with nephrosis and 29.2 years for patients with lupus glomeru-
lopathy). Membranous glomerulonephritis is more frequent in older age
(mean age 50 15.4). Nephrosis and membranous glomerulonephritis
seem to be the main histopathologic lesions in men with the nephrotic
syndrome. The distribution of these lesions varies with the study period.
Acute post-infectious glomerulonephritis has almost completely disap-
peared while HIV associated nephropathies increased (35.7% of biopsies
of men during the period 1990—1994). The number of diabetic glomeru-
lopathies diagnosed in women has grown. The incidence of primary
glomerular disease according to this study is l.9/year/100,000 inhabitants
(y/i) during the years 1988—1992. An average of 6.9 renal biopsies per y/i
were performed during these years. At the same time, the incidence of
end-stage renal disease due to primary glomerular disease is estimated to
be 2.01 per y/i by the local register of end stage renal disease. Nephrop-
athies of undetermined origin are evaluated to be 1.6 per y/i. The true
incidence of primary glomerulopathies seems to he largely underestimated
in this study. This could be due to: (a) a low level of health education of
the population, (b) lack of systematic screening among children of school
age and unemployed adults (30% of the population); (c) insufficient
screening and referral to nephrologist of patients by general practitioners.
In conclusion, this study underlines the high frequency of nephrosis in this
population and the importance of lupus glomerulopathies among young
women. Acute postinfeetious glomerulonephritis tends to disappear dur-
ing the study period while the number of HIV associated nephropathies
increases.
Changes in body composition during recombinant growth hormone
treatment in children. I. Liponsk4 P. Braillon, P. Cochat, Unite de
Nephrologie PCdiatrique, Hopital E Herriot, Lyon, France. Dual X-ray
absorptiometry (DEXA) is a means of assessing total body composition
with a 1 to 2% variation coefficient that allows longitudinal follow-up.
DEXA was performed in 9 children (4 girls) with chronic renal failure
(conservative treatment 1; hemodialysis 1; kidney transplantation 1) to
assess the changes in body composition during treatment with recombi-
nant human growth hormone (rHuGH). The patients who required
rHuGH received a daily subcutaneous injection (Genotonorm I U/kg!
week). The average age at the beginning of treatment was 14.3 (12.7 to
17.1) years for boys and 12.5 (8.8 to 15.0) for girls. Total body DEXA was
performed before rHuGH treatment, and then every 3 months during 14
(6 to 21) months. Thanks to a phantom of body composition made of
polymcthylmetaciylate and aluminum, it was possible to estimate the
absolute measurement and the percentage of bone mineral content
(BMC), fat body mass (FBM) and lean body mass (LBM). A significant
increase in LBM was shown: 3.6% after 6 months and 2.7% after 12
months in girls, 4.4% after 6 months and 5.5% after 12 months in boys.
PCR
mean (d)
AG
Table 3. AG duration and higher level AG among S VS AS
S
AS
109.5 23.2
50 26.9
458.5 187.7
161.6 222.3
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FBM decreased by 11.2% after 6 months and 10.7% after 12 months in
girls, and 12.4% after 6 months and 16.2% after 12 months in boys.
Consequently, a significant increase in LBM (P = 0.01) and a reduction in
FBM (P 0.004) were noted in both sexes. When compared to normal
values of LBM and FBM (in kg) in control children, the gain in LBM and
the loss in FBM was confirmed in 8 of 9 patients who received rHuGH for
1 year or more. The precision and the accuracy of total body composition
estimation by DEXA suggest that these preliminary results should be of
interest in evaluating the long-term nutritional effect of rHuGH in
children with chronic renal failure.
Value of magnetic resonnance angiography with the combination of
three dimentional time-of-flight and three dimentional phase contrast
sequences for the detection of renal artery stenosis. P. Loubeyre, R. Cohen,
P. Trolliet, F. Grozel, I. Durieu, J. Orgiazzi, R. Levrat, M. Labeeuw, VA.
Tran Minh, Services de Radiologie, Néphrologie, Médecine Interne, CHU
Lyon-Sod, Pierre Bénite, France. It has been reported that there is a high
number of pseudo-ostial stenoses, due to signal intensity loss, at the origin
of the renal arteries when using three dimentional (3D) phase contrast
(PC) magnetic resonnance angiography (MRA). Our goal was to add a 3D
time of flight (TOP) MRA sequence to the 3D PC MRA in order to better
analyze the initial part of the renal arteries. Forty-six patients, 29 men and
17 women, mean age 57 years (34 to 84), suspected of having renal artery
stenosis, were prospectively enrolled. The 2 MRA sequences and intra-
arterial digital subtraction angiography (IADSA) were performed in all
patients. MRA were interpreted by 2 radiologists who were unaware of the
findings of the IADSA. On 3D PC MRA, any signal cutoff or any
narrowing of more than 50% of the vessel diameter on the part of the
renal artery extending from the renal ostium to the renal hilium was
considered lobe a significant stenosis. For 3D TOP MRA, the analysis was
focused on the initial part of the renal artery; any signal eutoff was
considered to be a significant stenosis. IADSA showed 95 hilar renal
arteries and 7 small diameter polar supernumerary renal arteries; 11
significant (>50%) renal artery stenoses were noted on IADSA. When
considering only the hilar renal arteries as being stenotic or not using PC
MRA, the sensitivity was 100%, the specificity 65%, the positive predictive
value 28%, the negative predictive value 100% and accuracy 69%. When
using the combination of the two sequences, the specificity, the positive
predictive value and accuracy were increased to 90%, 58% and 92%,
respectively. Our results support the value of the combination of these two
MRA sequences for screening stenosis of the main renal arteries.
A familial case of optic nerve coloboma associated with renal disease.
G. Majdalani, C. Hocine, K Simoussa, T Yamauchi, G. Landthaler, G.
Brasseur, M. Godin, and J.P. Fillastre, Evreux Hospital and University
Hospital, Rouen, France. Optic nerve colobomas occur as sporadic abnor-
malities, as a dominantly inherited defect and as a part of renal syndromes.
We describe familial cases of optic nerve abnormality associated with
renal disease in three generations of a single family. Patient 1, N.M.
(mother) born in 1943, had renal insufficiency diagnosed in 1976 with mild
proteinuria without hematuria. She had ESRF and hemodialysis in 1987,
and a renal transplantation in 1988. Currently, N.M. has normal renal
function without proteinuria. Patient 2, C.L. (daughter), was born in 1964,
and had renal insufficiency diagnosed in 1982. An intravenous urography
revealed 2 atrophic kidneys. Renal biopsy demonstrated focal and seg-
mental hyalinosis associated with interstitial sclerosis. In 1985, she had
normal pregnancy and delivery. Currently C.L. has a stable renal function
(creatinine clearance 24 ml/min/1.73 m2). Patient 3, B.L. (grandson), was
born in 1985 with acute renal failure at birth and growth retardation.
Intravenous urography disclosed one functional kidney. Currently, he has
a stable renal function (creatinine clearance 89 ml/min/1.73 m2) without
proteinuria or hematuria. In all three patients, the visual fields by
pcrimetry showed a specific inferior nasal defect in the right and left visual
fields, which was confirmed by angiofluorography. This abnormality is
consistent with a defect of closure of the embryonic fissure of the optic
cup. HLA-typing (A2A3-B7B40, A1A3-B7BOO and A3A192-Bl5-B40,
respectively) showed a constant A3 type over all the family members. The
clinical picture of cavity optic disc abnormality and renal failure in this
family is consistent with a dominant autosomal mode of inheritance.
Dialysis prescription by liters of blood to process (LBP). G. Majdalani,
T Yamauchi, C. Hocine, Y. Ilakura, K. Sirnoussa, N.K Man, Evreux
Hospital and Necker Hopital, IIVSERM U90, Paris, France. Dialysis pre-
scription is based primarily on dialyzer urea clearance (K) and dialysis
duration (td), or in a more sophisticated way, on the Kt/V-urea. Several
recent dialysis monitors (in this study, Centrysystem 3 COBE) feature
total liters of blood to process (LBP) and it is proposed as a good
approach to the prescription of dialysis. The rationale is based on
clearance being defined as the product of extraction ratio (a) times blood
flow rate (Qb). Thus, Kt/V can be expressed as (aLBP)/V, where a is the
ratio of urea dialyzer clearance determined in vivo divided by the actual
blood flow rate during dialysis (K/Qb) and V is 58% of dry body weight
(BWf). To validate the concept, blood samples were withdrawn for urea
concentration determination at the start (Ci) and at the end (Cf) of 45
dialysis sessions lasting for 4 hours, performed on 8 stable dialysis patients.
The initial (BWi) and final (BWf) body weight were 53.3 1.9 and 50.5
1.7 kg for patients treated with AM BIO 50 WET (a = 0.61) and 62.1
2.4 and 58.8 2.3 kg with AM BIO 75 WET (a = 0.82) (HEMOTECH),
respectively. Results are shown on the table.
Dialyzer AM BIO 50 WET AM BIO 75 WET
Ci mmol/liter 31.3 1.0 28.5 1.0
Cf mmol/liter 9.1 0.7 8.0 0.4
lnCi/Cf (Kt/V) 1.3 0.1 1.3 0.1
aLBP/V (Kt/V) 1.4 0.1 1.5 0.1
LBP liter 70 2 67 1
LBP/BWf 1.4 0.1 1.2 0.1
Since lnCi/Cf correlated well with aLBP/V (y 0.66x + 0.32; r = 0.87;
N = 45), dialysis prescription could be done routinely by the liters of blood
to process. In this study, to achieve a mean Kt/V of 1.3, LBP were 70 liters
and 67 liters, or 1.4 and 1.2 liter/kg dry BW, respectively. In conclusion,
dialysis prescription by LBP is a simple and accurate method to achieve
adequacy of dialysis.
Hypertension and hyperkalemia without renal failure: Gordon's syn-
drome in a neonate. Th. Maroun, D. Chauveau, G. Pinto, G. Brillet, R.
Klink, J.P. Gain feld, Service of Nephrology and Pediatric Endocrinology,
Hôpital ATecker-Enfants Malades, Paris, and Pediatric Unit, Laon, France.
Asymptomatic hyperkalemia (7 mmol/liter) was found in a neonate
delivered by cesarian section at 35 weeks' gestation from a hypertensive
mother. Gestation was unremarkable, and birthweight was normal. Blood
pressure was at the upper limit of normal range for age (95/60 mm Hg).
Serum creatinine, chloride and biearbonates were 45 jzmol/liter, 105 and
13 mmol/liter, respectively. Arterial pH was 7.2. At 2 months of life normal
high blood pressure persisted, whereas serum potassium ranged between
5.5 to 6.5 mmol/liter. Hormonal studies documented plasma hyperaldo-
steronism (160 ng/dl, N < 13) and normal plasma renin activity (PRA) (4.8
ng/ml/hr; N = 3.3 to 26 for age range). In the maternal family, grandpar-
ents and an uncle were hypertensive. No information on their serum
potassium was available. In addition, the propositus' mother had been
hypertensive from 19 years of age. Despite combined use of a and 13
blockers, blood pressure remained elevated. Pregnancy was uneventful.
When first examined at our institution she was not receiving antihyper-
tensive therapy. Blood pressure was 150/116 mm Hg. Serum potassium,
chloride and bicarbonates were 5.7, 107 and 21 mmol/liter, respectively.
Tnulin clearance demonstrated normal GFR (125 ml/min/1.73 m2). Supine
plasma aldosterone was within normal range (mean 6.8 ng/dl, range 2—23)
whereas PRA was suppressed (0.4 ng/ml/hr, 0.6 to 3.5) and unresponsive
to upright posture (0.5, 2 to 5.3). ITydrochlorothiazide (25 mg/day)
completely reversed high blood pressure and serum potassium within 4
weeks. Gordon's syndrome was postulated. At least 71 cases have been
reported so far. Also called type IT pseudohypoaldosteronism or familial
hyperkalemic syndrome with normal renal function, this rare disorder is
inherited in 50% of cases, and then entails a dominant inheritance.
Hyperkalemia ranges from 5.6 to 9 mmol/liter, is usually asymptomatic
and associated with hyperchloremie metabolic acidemia and normal renal
function. Hypertension is usually severe. However, it was absent in 16 of
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71 children reported with the syndrome. Low PRA and constant respon-
siveness to thiazide diuretics strongly suggest salt-dependant hypertension.
Aldosteronism is alternatively high or normal despite hyperkalemia.
Mechanism(s) of the disease remain unknown, but could affect an ionic
channel as described in Liddle's syndrome.
Comparison of different methods of assessment of glomerular filtration
rate in patients with preterminal or terminal renal failure and persistent
diuresis. E. Marcu, ME Nord, N. Pozet, P. Cluzel, A. Cremault, and J.C.
Lebas de Lacour, Department of Internal Medicine and Hemodialysis, Centre
Hospitalier, Nevers, and Laboratory of Renal Functional Exploration, Hôpi-
tal Edouard Herriot, Lyon, France. The glomerular filtration rate (GFR),
usually assessed by creatinine clearance in a 24-hour urine sampling,
(CRC 24 hr) is used during preterminal renal failure (RF) to choose the
time of beginning extrarenal epuration and during terminal RF to help
quantify epuration (especially in case of peritoneal dialysis). The well
known limitations of CRC 24 hr may induce variability and decisional
mistakes. The aim of this study was to compare different methods of GFR
assessment in 16 patients (8 women, mean age 65 years, range 18 to 86)
with preterminal RF (3 patients) or terminal RF (it) in peritoneal dialysis,
3 in hemodialysis) with various etiologies and persistent diuresis (1 426
ml/24 hr, range 300 to 2,400). A functional renal exploration (FRE) with
coupled perfusion of paraaminohippuric acid (NEPHROTEST R) and
polyfructosan (INUTEST R) and minuted urine sampling during two (8
tests) to four (9 tests) periods of about 30 minutes was made. Seventeen
times (1 patient was assessed twice, at a 1 year interval) in moderate
Osmotic diuresis conditions (Mannitol 10%). This FRE allowed to calcu-
late inulin clearance (C1), PAH clearance (CPAH), creatinine clearance
(Cc-,), urea clearance (Ce), all expressed as mI/mm 1.73 m2 of body area,
as well as filtration fraction (FF = C[/CpAH), expressed as percentage.
FRE was preceded or followed by assessment of CRC 24 hr in a mean
time of 47 days (range 0 to 300). The Table indicates the results as mean
standard deviation and coefficient of correlation with INUC as well as the
coefficient of correlation between CRC and CRC 24 hr.
C1,, CPAH Cçr Cj
C1,, 6.9 3.3 22.8 13.3 9.4 5.5 6.3 3.1
r 1 0.85 0.79 0.89
CRC 24 hr — — 9.9 7.4 —
r 0.59
Ccr + CU 2 FF CRC 24 hr
C1,, 7.8 4.2 34 14 9.9 7.4
r 0.84 0.59
CRC24hr — — —
r
If Ci,, is considered as the gold standard for GFR measurement, it appears
that Cc-, and Cc, 24 hr overestimate it by 30%, are poorly correlated with
it, and poorly correlate with each other. The ratio Ccr + C/2 and C, in
the FRE conditions is nearest to C1,, values and better correlated with it.
However, in this type of patient (relatively low diuresis, high urinary dead
space?), urinary outputs are relatively low (2.2 1.7 mI/mm) and highly
variable during single testing (SD 0.59 0.98 mI/mm), inducing a high
variation of INUC during a single testing (standard deviation 1.89 2.08
ml/min/1.73 m2, coefficient of variation 27.5%). Whatever the method of
assessing glomerular filtration rate in patients with severe renal failure
with residual renal function, it must he integrated with other clinical or
nonclinical parameters to decide on beginning epuration in preterminal
RF or quantify epuration in terminal RF.
Evidence for anticipation in autosomal-dominant polycystic kidney
disease (ADPKD). P. Mazeau, R. Boulahrouz, C. Charasse, K.S. Ang, P. Le
Cacheux, P. Simon, Seivice de Néphrologie, CHG La Beauchée, St. Brieuc,
France. The possibility of genetic anticipation in ADPKD was recently
suggested by G.M. Fick et al (Kidney list 45:1153—62, 1994). We reviewed
84 pedigrees obtained during our prospective study on the natural history
of ADPKD in our region. Anticipation was defined as a 10-year earlier
Onset of end-stage renal disease (ESRD) in offspring as compared to their
affected parent. Due to the slowly progressive evolution of ADPKD, only
39 pedigrees (45.3%) with 69 parent-offspring pairs were informative. The
affected parent was the father in 18 families (14 father-son and 17
father-daughter pairs) and the mother in 21 families (19 mother-son and
19 mother-daughter pairs). Fifteen families (38%) showed ESRD antici-
pation in at least one offspring and that was as frequent with the affected
father (7/15) as with the affected mother (8/15). There were 16/69 pairs
(23%) with anticipation: 8/31 (26%) father-offspring pairs (5/14 father-son
and 3/17 father-daughter pairs), 8/38 (21%) mother-offspring pairs (5/19
mother-son and 3/19 father-daughter pairs). In 6 families (16%) with 11
pairs (16%), the offspring had ESRD two to nine years earlier than the
parent. In 5 families (12.8%) and 8 pairs (11%), the offspring entered
ESRD 10 or more years later than their parent (chi2 = 7.04, P < 0.01).
Affected fathers entered ESRD at 52 10 years of age and affected
mothers entered at 61 10 years of age (P < 0.01). When the transmitting
parent was the father, offspring entered ESRD at 50 7 years of age (sons
49 7 years and daughters 51 9 years) and when the transmitting
parent was the mother, offspring entered ESRD at 56 8 years (sons 57
10 years, P < 0.01 and daughters 55 6 years, P < 0.02). Our data suggest
ESRD anticipation in about 25% of ADPKD parent-offspring pairs.
However, our study does not confirm the influence of gender for antici-
pation.
IgA mesangial nephropathy in diabetic patients. C. Orfila, J. C, Lepert,
A. Modesto, B. Pipy, IM Sue, INSERM CJF 91-07, Service de Nephrologie,
C'HU Toulouse-Rangueil, France. Several reports have shown that glomer-
ulonephritis mediated by immune complexes can complicate diabetic renal
disease. Isolated cases of IgA mesangial nephropathy complicating dia-
betic glomerulosclerosis have been described. A retrospective study over
15 years was undertaken to define the concurrent renal diseases with the
presence of mesangial IgA deposits in selected patients who had diabetes
mellitus. Among a total of 66 patients who had renal biopsy performed for
diagnostic purposes and specimens available for immunofluorescence
study, 10 patients had IgA nephropathy in addition to diabetic ncphrop-
athy. The patients were admitted to the hospital for investigation of the
presence of microscopic hematuria, unexplained increase in the serum
creatinine level and/or absence of diabetic retinopathy. All patients had
IgA as the predominant immunoglobulin, located in the mesangium of all
glomeruli in each biopsy. Patients had no clinical signs of systemic lupus
erythematosus, Henoch-Schonlein purpura or cirrhosis of the liver. Age at
the onset or discovery of nephropathy ranged from 26 to 75 years (mean
55.6 years). There were 7 men and 3 women. Two patients presented with
nephrotic syndrome. All patients had proteinuria and 7 presented hema-
tuna. Four patients presented renal impairment ranging from 2 to 15
months. Duration of diabetes mellitus ranged from 3 to 20 years for 9
patients; it was not recorded for the last patient. Opthalmologic exami-
nation revealed proliferative diabetic retinopathy in 4 patients. Six pa-
tients presented with insulin-dependent diabetes mellitus and 4 patients
with non-insulin-dependent diabetes mellitus. Histologic examination
disclosed the presence of increased mesangial matrix in all eases, associ-
ated with segmental hypercellularity in 4 cases, mesangial sclerosis in 5
cases, nodular sclerosis in 8 cases and segmental and focal glomcrulotic-
phritis with crescent formation (2 out of 10 glomeruli) in one case. In all
cases, thcre was interstitial fibrosis with areas of tubular atrophy, and
arteriolar lesions were present. By immunofluorescenee, linear deposits of
IgG were observed along the glomerular basement membranes, associated
with mcsangial IgA deposits in all cases and C3 in 7 cases. In 5 cases, a
faint deposit of linear IgA associated with a strong granular mesangial
deposit of IgA was demonstrated. Segmental C3 deposits along the
Bowman's capsule were present in 7 cases. Linear lgG and or C3 deposits
were observed along the tubular basement membranes in 8 cases. Arte-
riolar C3 deposits were observed in all cases associated with deposits of
1gM (4 cases) and/or Clq (6 cases). By electron microscopy, thickening of
the glomerular basement membranes, fusion of the foot processes and
increase of the mesangial matrix were observed in all cases. Seven patients
showed nodular sclerosis and electron deposits were demonstrated in 8
cases. In conclusion, in patients with diabetes mellitus, the appearance of
urinary abnormalities and/or deterioration in renal function altered the
natural history of diabetic nephropathy. The disorders are clinically
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suggestive of the presence of non-diabetic renal disease and raise the
possibility of another pathogenetic mechanism.
A family history of hypertension is associated with nephrosclerosis and
predicts the future onset of hypertension in patients with IGA nephrop-
athy (IgAN). P. Simon, R. Boulahrouz, V Autuly, C. Charasse, P. Le
Cacheux, KS. Ang, MP. Ramée, Department of Nephrology, La Beauchée
Hospital, St Brieuc, and Department of Pathology, CHU Rennes, France. The
progress of IgAN is correlated with glomerular and vascular sclerosis.
Renal vascular lesions, that is, nephrosclerosis (N), often precede the
onset of hypertension (HBP) in young patients with IgAN (Am J Kidney
Dis 15:72, 1990). It is also recognized that a family history of HBP (FHBP)
is strongly predictive of future onset of HBP in family members, when two
or more first-degree relatives with HBP are identified (J Chron Dis 39:809,
1986). To examine the possible link between FHBP and N, we compared
2 groups of 29 patients each (23 M and 6 F) with IgAN, matched for age
and sex, according to the presence or absence of FHBP. FHBP was
considered present if at least 2 or more 1st degree relatives under 60 years
of age received antihypertensive Rx. Parents and siblings of pts were
examined at home by two investigators. Patients with FHBP (+) and
FHBP (—) were aged 36 12 and 35 12, respectively, at the time of
renal biopsy (RB) and follow-up was an average of 4.6 years. At the end
of this survey, HBP and renal failure (Ce. < 80 mI/mn) were re-evaluated
in all patients. At the time of RB, N was significantly associated with
FHBP: FHBP (+), 96.5% vs. FHBP (—), 10.3%, P < 0.0001. At the end
of follow-up, FHBP was found to be associated with HBP (89.6% vs.
10.3%, P < 0.0001) and with renal failure (44.8% vs. 3.4%, P < 0.001).
These data suggest that (1) N has a strong genetic component in patients
with IgAN. (2) FHBP is an early clinical indicator of N in these patients.
(3) FHBP is a strong indicator of unfavorable prognosis in IgAN.
